The Enterprise Value as of December 2024 (TTM) for Plus Therapeutics, Inc. (PSTV) is 8.55M

According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.55M. This represents a change of 0.22% compared to the average of 8.53M of the last 4 quarters.

Plus Therapeutics, Inc. (PSTV) Historical Enterprise Value (quarterly & annually)

How has PSTV Enterprise Value performed in the past?

The mean historical Enterprise Value of Plus Therapeutics, Inc. over the last ten years is 15.10M. The current 8.55M Enterprise Value has changed 5.56% with respect to the historical average. Over the past ten years (40 quarters), PSTV's Enterprise Value was at its highest in in the March 2015 quarter at 153.86M. The Enterprise Value was at its lowest in in the September 2019 quarter at -2230216.10.

Plus Therapeutics, Inc. (PSTV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Plus Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Plus Therapeutics, Inc. (PSTV) Average Enterprise Value

How has PSTV Enterprise Value performed in the past?

The current Enterprise Value of Plus Therapeutics, Inc. (PSTV) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Plus Therapeutics, Inc. (PSTV) Enterprise Value vs. Peers

How is PSTV’s Enterprise Value compared to its peers?

Plus Therapeutics, Inc.’s Enterprise Value is less than Aditxt, Inc. (12.41M), greater than Palisade Bio, Inc. (-2953174.00), greater than Revelation Biosciences, Inc. (-4029924.00), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), greater than Zura Bio Limited (-36740010.00), greater than Altamira Therapeutics Ltd. (501.91K), less than Immix Biopharma, Inc. (41.37M), greater than Enveric Biosciences, Inc. (40.99K), greater than First Wave BioPharma, Inc. (2.80M), greater than Dermata Therapeutics, Inc. (-3409123.00), greater than Panbela Therapeutics, Inc. (7.92M), greater than ContraFect Corporation (-2858930.00), less than Protara Therapeutics, Inc. (130.41M), greater than Vaccinex, Inc. (311.44K), less than Monopar Therapeutics Inc. (110.36M), less than Miromatrix Medical Inc. (90.06M), less than Surrozen, Inc. (10.29M), greater than Avenue Therapeutics, Inc. (935.74K), greater than Hoth Therapeutics, Inc. (-2555665.00), greater than NeuroBo Pharmaceuticals, Inc. (-1181216.00), greater than Virax Biolabs Group Limited (4.10M),

Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.